Metformin monotherapy for type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Metformin Monotherapy for Type 2 Diabetes Mellitus." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455534/all/Metformin_monotherapy_for_type_2_diabetes_mellitus.
Metformin monotherapy for type 2 diabetes mellitus. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/EBMG/455534/all/Metformin_monotherapy_for_type_2_diabetes_mellitus. Accessed April 19, 2026.
Metformin monotherapy for type 2 diabetes mellitus. (2026). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/455534/all/Metformin_monotherapy_for_type_2_diabetes_mellitus
Metformin Monotherapy for Type 2 Diabetes Mellitus [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2026. [cited 2026 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455534/all/Metformin_monotherapy_for_type_2_diabetes_mellitus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Metformin monotherapy for type 2 diabetes mellitus
ID - 455534
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455534/all/Metformin_monotherapy_for_type_2_diabetes_mellitus
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -

Evidence-Based Medicine Guidelines

